In this paper, an effective method of accelerating urokinase-administrated thrombolysis through a rotating magnetic field (RMF) of guided magnetic nanoparticles (NPs) in the presence of low-dose urokinase is proposed. The dispersed Fe 3 O 4 NPs mixed with urokinase were injected into microfluidic channels occluded by thrombus prepared in vitro. These magnetic NPs aggregated into elongated clusters under a static magnetic field, and were then driven by the RMF. The rotation of Fe 3 O 4 aggregates produced a vortex to enhance the diffusion of urokinase to the surface of the thrombus and accelerate its dissolution. A theoretical model based on convective diffusion was constructed to describe the thrombolysis mechanism. The thrombus lysis speed was determined according to the change of the thrombus dissolution length with time in the microfluidic channel. The experimental results showed that the thrombolysis speed with rotating magnetic NPs is significantly increased by nearly two times compared with using the same dose of pure urokinase. This means that the magnetically-controlled NPs approach provides a feasible way to achieve a high thrombolytic rate with low-dose urokinase in use.
Introduction
Thromboembolism is a common cardiovascular disease that threatens the life of human beings [1, 2] . After a thrombus forms and impedes a vessel, the oxygen and nutrition in the blood circulation system cannot be transported to the normal tissues and cells; then, a serious of complications may follow [3, 4] . Many clinical trials have proved the value of thrombolytic agents, such as urokinase [5] , streptokinase [6, 7] , tissue-type plasminogen activator (t-PA) [8] , and so on in the treatment of venous and arterial thromboembolic diseases. Large therapeutic doses of the agents are always needed to lyse the clot and reestablish antegrade blood flow for a shortened thrombolysis time [9, 10] . However, this may in turn result in the potential risks of symptomatic intracranial hemorrhages [11] [12] [13] . Therefore, other security methods to control the dose while improving the thrombolytic therapy rate should be sought. A few promising methods have been put forward. As a non-invasive technique, ultrasound is utilized to reduce the infusion time and provide a great incidence of complete lysis with a low rate of bleeding in treatment of deep-vein thrombosis (DVT) [14, 15] . The ultrasound accelerates thrombolysis by disaggregating the fibrin matrix and exposing additional plasminogen receptor sites to the thrombolytic agents [16] . An approximately half-dose reduction in urokinase, t-PA, and recombinant tissue plasminogen activator (r-tPA) is found for thrombolysis by using ultrasound. However, several safety factors, such as vascular wall injury and subsequent inflammation, still need to be considered to achieve an optimal risk-benefit ratio [17] . Another typical interventional effective therapy is nanomedicine delivery, which results from the combination of nanotechnology and biomedicine [18, 19] . Coated onto the surface [20, 21] or encapsulated into polymeric shells [22] , the magnetic nanoparticles (NPs) can transport the pharmaceuticals' molecules to the target lesion under the control of an external magnetic field. The conjugation of urokinase and NPs reduces the free diffusion of drug molecules in the flow, and raises the amount of medicament to thrombi. As a result, the efficiency in thrombolysis can be improved compared with pure urokinase application, which has been proven in our previous studies [23] . Shear-activated nanotherapeutics for drug targeting is another controlling method of NPs [24, 25] . The drug-coated NP aggregates fall apart and release the drugs only when encountering high fluid shear stress, which is the result of fluid flow at the narrow gap between the thrombus and the vessel wall. It helps restore the fluid flow at lower dose of drugs than free ones. However, the common process for the connection of drugs and NPs is always complicated, and may contain chemicals that are not suitable for use in vivo [26, 27] .
In order to solve the above problems, a new idea for the further diffusion of drug molecules toward the surface of thrombus occlusion by manipulating the movement of magnetic NPs is proposed to improve the thrombolysis efficiency. Our other study showed that Fe 3 O 4 NPs could aggregate into microrods under a static magnetic field, and then be controlled to move and rotate, thus producing a flow vortex and breaking thrombus directly [28] . However, small thrombus fragments may be generated during the crushing process, which may lead to new occlusion in some smaller capillaries [29, 30] . Here, the diffusion of thrombotic urokinase is enhanced under the influence of the convection flow, and then, more drugs can act on the thrombi to accelerate thrombolytic therapy than a pure agent without NPs. Since the thrombus is dissolved by drugs instead of being ablated by direct impact with the vortex flow or even the aggregates, no small blood clots will be produced. A thrombolysis model based on convection-enhanced diffusion theory is constructed to explain the thrombolysis acceleration process. The results of the thrombolytic experiments show that it is possible to apply this method in clinical practice in the future.
Materials and Methods

Preparation and Characterization of Magnetic Fe 3 O 4 NPs
In this study, the magnetic Fe 3 O 4 NPs were prepared with a modified co-precipitation method [21] . First, 1.0 g of FeCl 2 ·4H 2 O and 2.7 g of FeCl 2 ·6H 2 O were mixed in 50 mL of deionized water and heated to 80 • C under the protection of nitrogen atmosphere. Then, 25 mL of ammonia solution was added into the hot mixture drop by drop. The mixture was stirred and heated at 80 • C for 60 min. Subsequently, 2 g of citric acid dissolved in 10 mL of deionized water was added, and the temperature was raised to 90 • C under continuous stirring for 90 min. After cooling to room temperature, the black products were absorbed to the bottom of the reaction beaker by a strong magnet, and then the supernatant was removed. Subsequently, the sediment was washed four to five times until a pH of 7~8 was reached. Finally, the sediment was dried under flowing nitrogen at room temperature for one hour to obtain citric acid-coated Fe 3 O 4 NPs.
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Experimental System
Thrombolysis Model in Microfluidic Channel
In principle, the lysis of the thrombus is a process of diffusion and chemical reaction. A model of urokinase-mediated thrombolysis based on convective diffusion theory is here established to evaluate the thrombolytic effect of rotating NP aggregates. Thrombolysis involves a series of enzyme-catalyzed reactions, which are mainly divided into three processes: (1) urokinase molecules diffuse to the surface of the thrombus and react with the plasminogen bonded on the fibrin; (2) plasminogen is activated and converted into enzyme plasmin, which is responsible for the degradation of fibrin into a fibrin-hydrolyzed product; (3) hydrolyzed products are released and dissolved to expose new plasminogen for reaction. Considering a diffusion controlled process, the reaction rate can be expressed as r = 4πNa(D UK + D plm )C UK C plm [32] , where N is Avogadro's number, a is the encounter radius, D UK and C UK are the diffusion coefficient and concentration of urokinase, and D plm and C plm are the diffusion coefficient and concentration of plasminogen, respectively. Due to the plasminogen being bound on the fibrin, D plm can be seen as zero, and C plm can be seen as a constant, so r is mainly influenced by D UK and C UK . Since the reaction obviously starts from the contact boundary between the thrombus and urokinase, the lysis speed of the thrombus v lysis can be defined here as the moving distance of the thrombus boundary per unit of time in the occluded microfluidic channel. Note that r reflects the reduction rate of the thrombus mass over time, and the cross-sectional area in the microchannel is constant, so v lysis is proportional to r. Therefore, the lysis speed can be expressed as v lysis = kC UK D UK , where k is the reaction factor related to v lysis and D UK C UK , and is affected by N, a, and C plm .
For the case of pure urokinase, the diffusion coefficient of urokinase in the channel is usually a constant. Once a vortex is caused by the rotation of RMF-guided aggregates, the previously diffused urokinase would rotate about the rotation axis of the aggregates. Thus, the diffusion of urokinase can be expressed as D UK = D f + ∆D UK , where D f is the self-diffusion factor induced by pure urokinase, ∆D UK = bPe 2 D f [32] is the additional rotating diffusion factor, b is a proportional constant, and Pe is Peclet number. The Peclet number characterizes the ratio of the advection rate of a physical quantity by the flow to the diffusion rate of the same quantity driven by an appropriate gradient. In order to consider the convection created by the rotation of the paramagnetic particle chains, Biswal and Gast proposed the Peclet number as Pe = γ/(D f /l 2 ) [33] , where γ measures the time scale for stretching the fluid, and is proportional to the rotation angular velocity ω of the aggregate; l is the aggregate length; and l 2 /D f represents the diffusion time over a chain length. The diffusion coefficient is thus given as:
As it was known, the length of aggregate l has a nonlinear relationship with magnetic field strength H and NPs concentration C NP [28, 34] , so the length can be expressed as l 4 = k H α C NP β , where α and β are polynomial orders, and k is a correction factor. Accordingly, the thrombus boundary moving speed can be obtained as:
where v lysis_ f = kC UK D f is the lysis speed induced by the self-diffusion of urokinase, and ∆v lysis is the additional lysis speed caused by convective diffusion provided by the rotation of NPs.
Results and Discussions
Observation of Thrombolysis Enhancing by Magnetic Fe 3 O 4 NPs
Observation of the thrombolysis effect for urokinase solutions with and without magnetic Fe 3 O 4 NPs was first carried out. Four sets of small glass beakers were prepared, with each bottle containing 10 mL of deionized water and a little thrombus. The blood sample was collected from a healthy white mouse kindly provided by Tongji Hospital, Wuhan, China. The tiny amount of thrombus in each bottle was weighed with a precision balance in advance. Subsequently, 5 mg of urokinase was added to the first set of bottles, 5 mg of Fe 3 O 4 NPs were added to the second set of bottles, a mixture of 5 mg of urokinase and 5 mg of Fe 3 O 4 NPs was added to the third set of bottles, and the last set of bottles remained deionized water. The bottles with NPs were placed in the magnetic field area of our magnetic device. Each thrombolysis experiment was repeated five times, and the time from drug addition to the approximate disappearance of thrombus was recorded. The remaining thrombus in each bottle was removed from the bottle and weighed again at 30 min after each experiment. Figure 4 shows the experimental results, wherein the thrombolytic rate was calculated according to the amount of thrombus dissolution in the bottle over time. As shown, only a small amount of thrombolysis was observed in the control groups of pure water and NPs alone, which ensured that the thrombolytic rate was mainly based on the urokinase activity. The average thrombotic rate of pure urokinase is about 0.0025 g/min, which increased to 0.0035 g/min after adding the NPs. This shows that the thrombolytic effect is enhanced by 40% with the magnetic control of Fe 3 O 4 NPs.
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Thrombolysis Test In Vitro
In order to further demonstrate the thrombolytic function of the rotating nanoparticle clusters in vitro, a comparison of thrombolysis effects in the microfluidic channel that is shown in Figure 3c was performed. First, the urokinase solution with a concentration of 50 μg/mL was inserted into the thromboembolic channel from the inlet. The thrombolytic process of pure urokinase was observed for 220 s with the microscopic system at a magnification of 50×. Figure 5 shows some sequence images of the thrombus removal process intercepted from a recording video. As shown in these images, the moving boundary of the thrombus indicates that the thrombus was gradually removed with the diffusion of the injection urokinase. In this case, the boundary moves at an average speed of about 20 μm/min. 
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Conclusions
The introduction of magnetically controlled Fe3O4 NPs to promote the urokinase-administrated thrombolysis efficiency has been discussed in detail. The NPs are first aggregated into microrods under a static magnetic field; then, they are guided by a rotating magnetic field to induce a vortex, which strengthens the diffusion of urokinase toward the surface of the thrombus and results in the acceleration of thrombus removal. The thrombolysis speed is related to urokinase concentration, NP concentration, magnetic field strength, and the driving frequency of the rotating magnetic field. The experimental results validate the proposed model and prove that NPs can indeed improve thrombolytic efficiency. The thrombolysis speed can be enhanced to nearly two times higher than that of pure urokinase. It is expected that this method of accelerating thrombolysis may be applied in vivo in the future.
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